| Gene symbol | PDE6A | Synonyms | CGPR-A, PDEA, RP43 | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5q32 | dbXrefs | |
| Description | phosphodiesterase 6A | ||||
| GTO ID | GTC2495 |
| Trial ID | NCT04611503 |
| Disease | Retinitis Pigmentosa |
| Altered gene | PDE6A |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | rAAV-hPDE6A |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | PIGMENT - PDE6A Gene Therapy for Retinitis Pigmentosa |
| Year | 2020 |
| Country | Germany |
| Company sponsor | STZ eyetrial |
| Other ID(s) | RDC-PDE6A-01 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort1: dose level 1 | |||||||||
|
|||||||||
| Cohort2: dose level 2 | |||||||||
|
|||||||||
| Cohort3: dose level 3 | |||||||||
|
|||||||||